It can support healthy weight management, but it cannot [provide the] drastic weight loss results you would experience with a drug like Ozempic, he said
To view or add a comment, sign in GLP-1 therapy has moved from glucose control to true cardio-renal disease modification
Does stress reduce GLP-1 levels
[FDA Brief ZepBound] The compounding pharmacies have been providing much cheaper versions of the drugs and apparently different dosing regimens
Koppula P, Zhang Y, Shi J, Li W, Gan B
Orforglipron's signaling profile has been characterized in the peer-reviewed publication in Science Translational Medicine in 2024, which reported that orforglipron demonstrates a Gs-biased signaling profile with relatively reduced beta-arrestin recruitment compared to peptide agonists